Top Reasons to Get Hemophilia Gene Therapy in Israel
Groundbreaking Treatment to Save Lives: Hemophilia Therapy
Hemophilia is a life-threatening blood disorder in which a person lacks blood-clotting proteins called clotting factors. Until now, this rare blood condition could only be managed through recurring injections or infusions. Hemophilia gene therapy is a phase 3 clinical trial and groundbreaking new treatment for hemophilia based on genetic engineering with the goal of treating the disease for life using one single dose.
Very few hospitals in the world offer hemophilia gene therapy. Already known for its cutting-edge technology and innovative clinical trials, Israel is home to the first medical institution that made hemophilia gene therapy available to medical tourists.

Request a consultation
Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.
We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.
Request a consultation and a Sheba Case Manager will contact you shortly: